MARKET WIRE NEWS

argenx SE (NASDAQ: ARGX Message Board Post 217440


Posted By: (investorshub) @riche

Posted on: Oct/17/2018 08:09:07

Efgartigimod is a first-in-class antibody fragment designed for

Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144266666


Subscribe to Our Newsletter


Message Board Posts


investorshub : Monksdream
investorshub : Monksdream
investorshub : Monksdream
investorshub : Monksdream

Download The Market Wire News App

Link Market Wire News to Your X Account